Pitofsky Jason
Reporting owner on Forms 3, 4 and 5, CIK 2009236.
Pitofsky Jason reported on 1 issuer in 1 filing, the latest a Form 4 filed 2026-11-06.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| REGN · REGENERON PHARMACEUTICALS, INC.CIK 872589 | officer (SVP Controller) | 1 | 2026-11-06 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| REGN · REGENERON PHARMACEUTICALS, …Common Stock | 2026-11-04 | M exercised | +1,500 | $726.53 | 5,772 | Form 4 |
| REGN · REGENERON PHARMACEUTICALS, …Common Stock | 2026-11-04 | M exercised | +1,478 | $644.54 | 7,250 | Form 4 |
| REGN · REGENERON PHARMACEUTICALS, …Common Stock | 2026-11-04 | M exercised | +905 | $492 | 8,155 | Form 4 |
| REGN · REGENERON PHARMACEUTICALS, …Common Stock | 2026-11-04 | S sold | -439 | $939.57 | 7,716 | Form 4 |
| REGN · REGENERON PHARMACEUTICALS, …Common Stock | 2026-11-04 | S sold | -575 | $940.46 | 7,141 | Form 4 |
| REGN · REGENERON PHARMACEUTICALS, …Common Stock | 2026-11-04 | S sold | -982 | $941.58 | 6,159 | Form 4 |
| REGN · REGENERON PHARMACEUTICALS, …Common Stock | 2026-11-04 | S sold | -1,215 | $942.31 | 4,944 | Form 4 |
| REGN · REGENERON PHARMACEUTICALS, …Common Stock | 2026-11-04 | S sold | -529 | $943.53 | 4,415 | Form 4 |
| REGN · REGENERON PHARMACEUTICALS, …Common Stock | 2026-11-04 | S sold | -108 | $944.22 | 4,307 | Form 4 |
| REGN · REGENERON PHARMACEUTICALS, …Common Stock | 2026-11-04 | S sold | -35 | $945.61 | 4,272 | Form 4 |
| REGN · REGENERON PHARMACEUTICALS, …Common Stock | 2026-11-04 | S sold | -179 | $950.76 | 0 | Form 4 |
| REGN · REGENERON PHARMACEUTICALS, …Common Stock, holding | 48 | Form 4 | ||||
| REGN · REGENERON PHARMACEUTICALS, …Non-Qualified Stock Option (right to bu…, derivative | 2026-11-04 | M exercised | -905 | $0 | 0 | Form 4 |
| REGN · REGENERON PHARMACEUTICALS, …Non-Qualified Stock Option (right to bu…, derivative | 2026-11-04 | M exercised | -1,478 | $0 | 500 | Form 4 |
| REGN · REGENERON PHARMACEUTICALS, …Non-Qualified Stock Option (right to bu…, derivative | 2026-11-04 | M exercised | -1,500 | $0 | 2,478 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0002009236-26-000003 | REGENERON PHARMACEUTICALS, INC. | 2026-11-06 |